Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. GNVCA hires eminent association leader as inaugural executive director

    ... and was Tennessee communication director for the American Cancer Society. Byrd also served as legislative director for a ...

    sommers - 03/28/2024 - 8:39am

  2. Immunotherapies linked to specific heart complications

    ... The study, published online Nov. 12 in  The Lancet Oncology , augments previous work by Vanderbilt University Medical Center ... “When the immune system wakes up to attack the cancer cells, in rare situations it can also attack the heart and vessels, and ...

    sommers - 02/21/2019 - 9:51am

  3. Vanderbilt University, Medical Center reach $1B milestone together in research funding

    ... molecules involved in tumor progression in pancreatic cancer, the third leading cause of cancer deaths in the U.S. This ongoing ... said Jennifer Pietenpol, Benjamin F. Byrd Jr. Professor of Oncology and VUMC chief scientific and strategy officer. “In addition, ...

    sommers - 05/23/2022 - 1:25pm

  4. ThermoFisher Scientific - Research Interest Areas

    ... analysis; fluorescent probes for measuring cell health & content; functional flow cytometry reagents; fluorescent assays run on Qubit ... Cell and Gene Therapy T cell therapy; cancer vaccine; gene delivery system; lentivirus, adeno-associated virus ...

    cttc_admin - 01/30/2024 - 12:26pm

  5. Diagnostics Management Team

    ... Field of Use: Oncology Featured:  0 Priority:  0 Case manager:  ...

    cttc_admin - 01/23/2024 - 1:37pm

  6. Small Molecule mGlu3 NAMs as Therapeutics for CNS Disorders

    ... therapeutic to many neurological disorders and well as oncology through the use of dual specific mGlu2/3 Antagonists (LY341495, ... Small Molecule Featured:  0 Priority:  1 Case manager:  ...

    cttc_admin - 01/23/2024 - 4:43pm

  7. Nashville Biosciences and Illumina announce agreement to establish preeminent clinico-genomic resource for life sciences research & development

    ... multiple pharmaceutical industry partners to perform whole genome sequencing on approximately 250,000 de-identified DNA samples collected ... to understand a wide range of health conditions, from cancer to heart disease, as well as genetic factors that increase the risk for ...

    sommers - 01/11/2022 - 11:06am

  8. Innovation Catalyst Fund announces eight inaugural awardees; next round submission deadline is April 15

    ... reading aids for children to enhanced therapies for breast cancer patients—shows an impressive range of faculty-led innovations that ... hold (DIBH) to improve radiation therapy outcomes in breast cancer patients” The  Innovation Catalyst Fund Review Committee ...

    sommers - 02/13/2024 - 10:43am

  9. Study seeks to boost breast tumor immune response

    ... of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer. ... professor of Medicine, serves as leader of Molecular Oncology in the VICC Center for Cancer Targeted Therapies. Read the rest of ...

    sommers - 02/13/2018 - 9:01am

  10. Five researchers from VUMC among most highly cited

    ... and co-leader of Translational Research and Interventional Oncology at the Vanderbilt-Ingram Cancer Center, and an expert in cancer immunotherapy. Dan Roden , MD, ...

    sommers - 11/24/2021 - 9:05am